Mallinckrodt PLC (NYSE:MNK) was upgraded by investment analysts at EVA Dimensions from an “underweight” rating to a “hold” rating in a note issued to investors on Friday, AnalystRatings.NET reports. Mallinckrodt PLC (NYSE:MNK) stock opened at $67.31 in last trading session, and closed at $68.13, trading in the range of $65.91 – $69.00. The stock showed a positive weekly performance of 0.68%.
Zoetis Inc (NYSE:ZTS)‘s stock had its “buy” rating reiterated by stock analysts at Jefferies Group in a report issued on Tuesday, American Banking News reports. They currently have a $37.00 price objective on the stock, down from their previous price objective of $38.00. Jefferies Group’s price objective suggests a potential upside of 21.71% from the company’s current price. Zoetis Inc (NYSE:ZTS) shares closed at $30.58 on last trade day, by losing -0.65%. Stock 52 week range is $28.77 – $35.42. Company’s market capitalization is $15.29 billion.
Momenta Pharmaceuticals (NASDAQ:MNTA) was downgraded by equities researchers at TheStreet from a “hold” rating to a “sell” rating in a research report issued on Wednesday, StockRatingsNetwork.com reports. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) stock advanced 0.74% and finished the last session at $15.01. The EPS of the stock remained -2.12. Company’s market capitalization is $784.86 billion.
Equities research analysts at Aegis upped their target price on shares of Galectin Therapeutics (NASDAQ:GALT) from $16.00 to $32.00 in a research note issued to investors on Monday, American Banking and Market News reports. The firm currently has a “buy” rating on the stock. Aegis’ target price points to a potential upside of 130.05% from the stock’s previous close. Galectin Therapeutics Inc. (NASDAQ:GALT) stock opened at $16.11 in last trading session and closed at $15.15. The 52 week range of the stock is $3.05 – $19.11 and the day range was $14.81 – $16.26.